Imugene Limited (ASX:IMU) is a clinical stage immuno-oncology company involved in developing a range of new and novel immunotherapies that seek to activate a cancer patient’s immune system to detect and eliminate tumours. Over the years, it has grown tremendously to become one of the top three largest biotech companies in Australia.
Imugene bringing effective new treatments and options to cancer patients
GET A FREE STOCK REPORT
Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.
Be the First to Comment